Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2026-05-10 @ 9:06 PM
Study NCT ID:
NCT04812002
Status:
RECRUITING
Last Update Posted:
2022-06-03
First Post:
2021-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CSEM018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None